Results 11 to 20 of about 17,907 (178)

Progress of clinical therapies for dry age-related macular degeneration [PDF]

open access: yesInternational Journal of Ophthalmology, 2022
Dry age-related macular degeneration (AMD) is a progressive blinding disease that currently affects millions of people worldwide with no successful treatment available.
Rhianna Rubner   +2 more
doaj   +5 more sources

Improvement in Dry Age-Related Macular Degeneration with Photobiomodulation [PDF]

open access: yesCase Reports in Ophthalmology
Introduction: This case report describes a finding of dramatic improvement in drusen volume and visual acuity in a 73-year-old patient diagnosed with dry age-related macular degeneration (AMD) undergoing daily home photobiomodulation alongside
Patrick Xiang Ji   +3 more
doaj   +4 more sources

Treatment of dry age‐related macular degeneration: A review

open access: yesClinical and Experimental Ophthalmology, 2023
AbstractAge‐related macular degeneration is a global disease with a significant societal impact. The advent of anti‐vascular endothelial growth factor therapy (anti‐VEGF) has revolutionised the treatment of neovascular age‐related macular degeneration (nAMD).
Shenouda Girgis, Lawrence R Lee
exaly   +5 more sources

Long-Term Follow-Up of Dry Age-Related Macular Degeneration Patients [PDF]

open access: yesJournal of Current Ophthalmology
Purpose: To assess the progression rate from dry age-related macular degeneration (dAMD) to advanced AMD and possible risk factors. Methods: Demographics, medical and ocular conditions, baseline eye examinations, optical coherence tomography features ...
Elham Sadeghi   +8 more
doaj   +2 more sources

Imaging Characteristics of Dry Age-Related Macular Degeneration

open access: yesSeminars in Ophthalmology, 2011
To review the current literature regarding the imaging characteristics of dry age-related macular degeneration (AMD) lesions, with a special focus on drusen and geographic atrophy imaging. We also explore the role of novel approach of hyperspectral imaging in AMD.Review of current literature as well as findings in a small group of patients imaged with ...
Mahsa A Sohrab   +2 more
exaly   +4 more sources

Multiwavelength Photobiomodulation Improves Multiple Aspects of Visual Function in Early-Stage Dry Age-Related Macular Degeneration [PDF]

open access: yesOphthalmology and Therapy
Introduction This study aimed to evaluate the safety and efficacy of multiwavelength photobiomodulation (PBM) treatment (Tx) in earlier stages of nonexudative (dry) age-related macular degeneration (AMD).
Cem Küçükerdönmez   +1 more
doaj   +2 more sources

Choriocapillaris Flow and Retinal Vascular Fractal Dimension in Dry Age-Related Macular Degeneration [PDF]

open access: yesDiagnostics
Background/Objective: To evaluate the association between optical coherence tomography angiography (OCTA)-derived choriocapillaris flow (CCflow), retinal vascular fractal dimension (FD), and drusen burden in eyes with dry age-related macular degeneration
Mine Ozturk, Abdullah Ağın
doaj   +2 more sources

Nutrient supplementation for age-related macular degeneration, cataract, and dry eye

open access: yesJournal of Ophthalmic & Vision Research, 2014
There have been enormous advances in the past decade for the treatment of age-related macular degeneration (AMD); however, these treatments are expensive and require frequent follow-up and injections which place a tremendous burden on both the healthcare
Ronald P Hobbs, Paul S Bernstein
doaj   +3 more sources

Recent developments in the management of dry age-related macular degeneration

open access: yesClinical Ophthalmology, 2015
Elisa Buschini, Antonio M Fea, Carlo A Lavia, Marco Nassisi, Giulia Pignata, Marta Zola, Federico M Grignolo Ospedale Oftalmico, Ophthalmic Section, Department of Clinical Pathophysiology, University of Turin, Turin, Italy Abstract: Dry age-related ...
Buschini E   +6 more
doaj   +6 more sources

Antioxidants and Mechanistic Insights for Managing Dry Age-Related Macular Degeneration [PDF]

open access: yesAntioxidants
Age-related macular degeneration (AMD) severely affects central vision due to progressive macular degeneration and its staggering prevalence is rising globally, especially in the elderly population above 55 years. Increased oxidative stress with aging is
Deepak Basyal, Sooyeun Lee, Hye Jin Kim
doaj   +2 more sources

Home - About - Disclaimer - Privacy